Watch XAGEW. Know when insiders buy.
One email the day a filing lands. Free.
XAGEW
Longevity Health Holdings, Inc.
No price history available
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
50
WATCH · shorts 50
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $1.7M +60.3%NET INCOME −$6.8MNET DEBT $9.3M52W —SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $396K | −21.4% | 59.5% | −$724K | −$1.9M | — | -0.76 | −$224K | — | — | Aug 14 |
| Q1 2026 · Mar 31 | $392K | −23.2% | 60.5% | −$1.3M | −$1.4M | — | -0.75 | −$485K | — | — | May 15 |
| Q4 2025 · Dec 31derived | $473K | +2606.0% | 56.6% | −$2.3M | −$2.1M | — | -1.15 | −$306K | $1 | −$306K | Mar 31 |
| Q3 2025 · Sep 30 | $426K | +1975.5% | 59.8% | −$1.5M | −$1.4M | — | -0.83 | −$1.4M | — | — | Nov 14 |
| Q2 2025 · Jun 30 | $504K | +3987.8% | 60.1% | −$1.9M | −$1.9M | — | -1.56 | −$836K | — | — | Aug 14 |
| Q1 2025 · Mar 31 | $510K | — | 52.9% | −$1.5M | −$1.5M | — | -1.52 | −$753K | — | — | May 15 |
| Q4 2024 · Dec 31derived | $17K | — | 93.0% | −$1M | −$914K | −129.0% | -1.37 | −$772K | — | — | Mar 31 |
| Q3 2024 · Sep 30 | $21K | — | 76.4% | −$1.4M | −$2.9M | — | -4.13 | −$907K | — | — | Nov 14 |
| Q2 2024 · Jun 30 | $12K | — | 97.6% | −$1.2M | −$3.3M | — | -4.78 | −$1.1M | — | — | Aug 14 |
| Q1 2024 · Mar 31 | $0 | — | — | −$1.4M | −$3.3M | — | -4.28 | −$1.1M | — | — | May 15 |
| Q4 2023 · Dec 31derived | $0 | — | — | −$333K | $3.2M | — | 1.35 | −$3.4M | $0 | −$3.4M | Jun 17 |
| Q3 2023 · Sep 30 | $0 | — | — | −$2.8M | −$11.5M | — | -0.62 | −$4M | $0 | −$4M | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.9M | 57.2% | −$7.1M | −$6.9M | -361.0% | -4.83 | −$3.3M | $14K | −$3.3M | — | — |
| FY2024 · to Dec 31 | $50K | 87.4% | −$5M | −$10.4M | -20605.5% | -14.56 | −$3.9M | — | — | — | — |
| FY2023 · to Dec 31 | $0 | — | −$5.9M | −$15.4M | — | -1.46 | −$8.3M | $30K | −$8.4M | $0 | — |
| FY2022 · to Dec 31 | — | — | −$5.5M | −$9.1M | — | -5.47 | −$3.4M | $7K | −$3.4M | $2K | — |
| FY2021 · to Dec 31 | — | — | −$467K | −$329K | — | — | −$451K | — | — | — | — |
Every number comes from Longevity Health Holdings, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.